List view / Grid view

Repatha (evolocumab)



FDA approves LDL cholesterol drug Repatha

28 August 2015 | By Victoria White

Repatha, the second drug approved in a new class of drugs known as PCSK9 inhibitors, has been approved by the FDA for some patients who are unable to get their LDL cholesterol under control with current treatment options...